Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

A recent study has tried to understand the correlation between normal weight obesity — NWO — and Type 2 diabetes. The study, ...

Bio-Path Holdings Inc.’s stock (BPTH) soared over 150% Thursday afternoon, hitting levels last seen in August, making it the ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. On the other hand, DexCom has attractive ...

Liver disease can affect anyone, not just heavy drinkers. Learn about the hidden risks and how to protect your liver health ...

Study links faster walking pace to reduced risk of diabetes, hypertension, and dyslipidemia in obese individuals.

The study reveals a strong association between walking speed and metabolic disease risk in obesity, suggesting fast walking ...

Type 2 diabetes risk among obese people reduced by tirzepatide Chemical in ultra-processed foods could cause leaky gut and ...

Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...

Find out how long you should walk every day to manage diabetes and improve your health. Learn how many steps you need and the ...